Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS)

Haemophilia A treatment with factor VIII concentrates requires frequent venipunctures; a central venous access device (CVAD) may be required to facilitate reliable venous access, especially in young children. While CVADs provide reliable venous access, complications such as infection and thrombosis may occur.

[1]  M. Bullinger,et al.  Why should we care about quality of life in persons with haemophilia? , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  V. Rodriguez,et al.  Central venous access devices for paediatric patients with haemophilia: a single‐institution experience , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  E. Santagostino,et al.  Barriers to primary prophylaxis in haemophilic children: the issue of the venous access. , 2008, Blood transfusion = Trasfusione del sangue.

[4]  P. Mannucci,et al.  Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters , 2008, British journal of haematology.

[5]  J. Journeycake,et al.  Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  F. Rosendaal,et al.  Social participation of patients with hemophilia in the Netherlands. , 2008, Blood.

[7]  M. Bullinger,et al.  The economics of haemophilia prophylaxis: governmental and insurer perspectives. PROCEEDINGS OF THE SECOND INTERNATIONAL PROPHYLAXIS STUDY GROUP (IPSG) SYMPOSIUM , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[9]  J. Rich-Edwards,et al.  Central Venous Access Device Infections in Children With Hemophilia: A Comparison of Prophylaxis and Episodic Therapy , 2007, Journal of pediatric hematology/oncology.

[10]  V. Blanchette,et al.  Definitions for haemophilia prophylaxis and its outcomes: The Canadian Consensus Study , 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  P. Babyn,et al.  Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study , 2006, Journal of thrombosis and haemostasis : JTH.

[12]  J. Oldenburg,et al.  Haemophilia A: from mutation analysis to new therapies , 2005, Nature Reviews Genetics.

[13]  R. Ljung,et al.  Optimizing factor prophylaxis for the haemophilia population: where do we stand? , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[14]  R. Ljung.  Central venous catheters in children with haemophilia. , 2004, Blood reviews.

[15]  A. Daneman,et al.  A prospective, longitudinal study of central venous catheter‐related deep venous thrombosis in boys with hemophilia , 2004, Journal of thrombosis and haemostasis : JTH.

[16]  L. Valentino,et al.  Central venous access devices in haemophilia , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  J. Journeycake,et al.  Thrombotic complications of central venous catheters in children , 2003, Current opinion in hematology.

[18]  L. Peddle,et al.  Surveillance of infectious complications associated with central venous access devices in children with haemophilia , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  V. Blanchette,et al.  A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[20]  W. Schramm,et al.  Economics of prophylactic treatment , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[21]  R. Janco,et al.  Complications of central venous access devices in paediatric haemophilia patients , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[22]  K. Kurnik,et al.  Catheter-related thrombosis in children with hemophilia A: evidence of a multifactorial disease. , 2002, Blood.

[23]  K. Khair,et al.  Central venous access devices in children with congenital coagulation disorders: complications and long‐term outcome , 2000, British journal of haematology.

[24]  R. Ljung,et al.  Port‐A‐Cath usage in children with haemophilia: experience of 53 cases , 1998, Acta paediatrica.

[25]  J. Sanders,et al.  Implantable venous access devices in children with hemophilia: a report of low infection rates. , 1998, The Journal of pediatrics.

[26]  D. Kleinert,et al.  Use and morbidity of venous access devices in patients with hemophilia. , 1998, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[27]  Rollins,et al.  Contrast venography in young Haemophiliacs with implantable central venous access devices , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

[28]  K. Khair,et al.  Complications experienced with central venous catheters in children with congenital bleeding disorders , 1997, British journal of haematology.

[29]  V. Blanchette,et al.  Central venous access devices in children with hemophilia: an update. , 1997, Blood Coagulation and Fibrinolysis.

[30]  I. Warrier,et al.  Use of central venous catheters in children with haemophilia: one haemophilia treatment centre experience , 1997, Haemophilia : the official journal of the World Federation of Hemophilia.

[31]  V. Blanchette,et al.  Central venous access catheters in children with haemophilia. , 1996, Blood Coagulation and Fibrinolysis.

[32]  A. Vora,et al.  Use of central venous catheters in children with severe congenital coagulopathy , 1995, British journal of haematology.

[33]  R. Ljung,et al.  Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia , 1992, Acta paediatrica.

[34]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.

[35]  L. Rubin,et al.  Infection rates of Broviac-Hickman catheters and implantable venous devices. , 1988, American journal of diseases of children.

[36]  D. Crivellari,et al.  A Single-Institution Experience , 2013 .

[37]  C. Moertel,et al.  The use of implantable venous access devices (IVADs) in children with hemophilia. , 1997, Journal of pediatric hematology/oncology.